Why Poseida Therapeutics Shares Are Trading Higher By… - inkl

1 day ago · Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) rose sharply in today's pre-market trading after the company agreed to be acquired by Roche in a $1.5 billion deal. …

CouponFollow Extension

$1
OFF

Why Poseida Therapeutics Shares Are Trading Higher By… - Inkl

2 days from now

1 day ago · Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) rose sharply in today's pre-market trading after the company agreed to be acquired by Roche in a $1.5 billion deal. …

inkl.com

$1
OFF

Why Poseida Therapeutics Shares Are Trading Higher By 219

2 days from now

1 day ago · Shares of Poseida Therapeutics, Inc. PSTX rose sharply in today's pre-market trading after the company agreed to be acquired by Roche in a $1.5 billion deal. Poseida Therapeutics …

benzinga.com

219%
OFF

Why Poseida Therapeutics Shares Are Trading Higher By 219%; …

2 days from now

1 day ago · Shares of Poseida Therapeutics, Inc. NASDAQ:PSTX rose sharply in today's pre-market trading after the company agreed to be acquired by Roche in a $1.5 billion …

tradingview.com

$50
OFF

Why Are Poseida Therapeutics Shares Moving Higher Today?

2 days from now

Aug 7, 2023 · Poseida Therapeutics Inc PSTX shares are trading higher after the company received a $50 million strategic investment by Astellas Pharma Inc ALMPY ALMPF.. The …

benzinga.com

6%
OFF

Why Poseida Therapeutics Is Trading Higher By Around 100

2 days from now

Aug 3, 2022 · Poseida Therapeutics, Inc. PSTX shares jumped 99.6% to $4.85 as the company ... Chembio Diagnostics is expected to release financial results for the second quarter after the …

benzinga.com

$50
OFF

Why Are Poseida Therapeutics Shares Moving Higher Today?

2 days from now

Poseida Therapeutics Inc (NASDAQ:PSTX) shares are trading higher after the company received a $50 million strategic investment by Astellas Pharma Inc (OTC:ALMPY) (OTC:ALMPF).. The …

webull.com

6%
OFF

Why Poseida Therapeutics Almost Doubled Today, Here Are 75 …

2 days from now

Aug 3, 2022 · Poseida Therapeutics, Inc. (NASDAQ:PSTX) shares jumped 99.6% to $4.85 as the company entered into a strategic collaboration and license agreement with Roche Holdings …

businessinsider.com

70%
OFF

Why Poseida Therapeutics Almost Doubled Today, Here… - Inkl

2 days from now

Aug 3, 2022 · Kintara Therapeutics, Inc. (NASDAQ:KTRA) gained 70% to $0.3013 after the company entered into an equity purchase agreement with Lincoln Park Capital for up to $20 …

inkl.com

70%
OFF

Poseida Therapeutics, Inc. (PSTX) Is Up 24.70% In One Week

2 days from now

Nov 12, 2024 · Over the past quarter, shares of Poseida Therapeutics, Inc. Have risen 25.34%, and are up 76.67% in the last year. On the other hand, the S&P 500 has only moved 12.69% …

nasdaq.com

56%
OFF

Are You Looking For A Top Momentum Pick? Why Poseida …

2 days from now

Shares of Poseida Therapeutics, Inc. Have increased 57.56% over the past quarter, and have gained 67.36% in the last year. On the other hand, the S&P 500 has only moved 11.02% and …

msn.com

9%
OFF

Wall Street Analysts Think Poseida Therapeutics (PSTX) Could …

2 days from now

15 hours ago · Shares of Poseida Therapeutics, Inc. (PSTX Quick Quote PSTX - Free Report) have gained 282.9% over the past four weeks to close the last trading session at $9.38, but …

zacks.com

189%
OFF

Wall Street Analysts See An 189% Upside In Poseida Therapeutics, …

2 days from now

Dec 6, 2022 · Shares of Poseida Therapeutics, Inc. (PSTX Quick Quote PSTX - Free Report) have gained 14.6% over the past four weeks to close the last trading session at $5.10, but …

zacks.com

56%
OFF

Are You Looking For A Top Momentum Pick? Why Poseida …

2 days from now

Jul 19, 2024 · Shares of Poseida Therapeutics, Inc. Have increased 57.56% over the past quarter, and have gained 67.36% in the last year. On the other hand, the S&P 500 has only …

tradingview.com

70%
OFF

Poseida Therapeutics, Inc. (PSTX) Is Up 24.70% In One Week: What …

2 days from now

Over the past quarter, shares of Poseida Therapeutics, Inc. Have risen 25.34%, and are up 76.67% in the last year. On the other hand, the S&P 500 has only moved 12.69% and 37.58%, …

msn.com

2%
OFF

Why Poseida Therapeutics Stock Is Popping Today

2 days from now

Feb 24, 2021 · Shares of Poseida Therapeutics (NASDAQ:PSTX) were jumping 21.2% higher as of 12:08 p.m. EST on Wednesday. The big gain came with the company providing a pipeline …

fool.com

49%
OFF

Poseida Therapeutics (PSTX) Stock Price, News & Analysis

2 days from now

5 days ago · Poseida Therapeutics scored higher than 49% of companies evaluated by MarketBeat, and ranked 273rd out of 946 stocks in the medical sector. Scores are calculated …

marketbeat.com

$50
OFF

Why Are Poseida Therapeutics Shares Moving Higher Today?

2 days from now

Aug 7, 2023 · Poseida Therapeutics Inc NASDAQ:PSTX shares are trading higher after the company received a $50 million strategic investment by Astellas Pharma Inc (OTC: ALMPY) …

tradingview.com

$9.50
OFF

Poseida Therapeutics (NASDAQ:PSTX) Lowered To "Hold

2 days from now

15 hours ago · According to MarketBeat, Poseida Therapeutics presently has an average rating of "Hold" and an average price target of $9.50. Check Out Our Latest Report on Poseida …

marketbeat.com

9%
OFF

Why Nutanix Shares Are Trading Higher By 9%; Here Are… - Inkl

2 days from now

15 hours ago · Shares of Nutanix, Inc. (NASDAQ:NTNX) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Nutanix …

inkl.com

FAQs about Why Poseida Therapeutics Shares Are Trading Higher By… - inkl Coupon?

How much does poseida Therapeutics stock cost?

The stock... Poseida Therapeutics Inc. said Thursday it will offer 14 million share in its initial public offering, priced at $16 each, up from an earlier plan to offer 10 million share priced at $14 to $16 each. The company expects t... ...

How much did poseida Therapeutics raise in an IPO?

Poseida Therapeutics (PSTX) raised $150 million in an initial public offering on Friday, July 10th 2020. The company issued 10,000,000 shares at $14.00-$16.00 per share. BofA Securities, Piper Sandler and William Blair served as the underwriters for the IPO. Who are Poseida Therapeutics' major shareholders? ...

Do institutional investors like poseida Therapeutics?

So they usually pay more attention to companies that are included in major indices. As you can see, institutional investors have a fair amount of stake in Poseida Therapeutics. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. ...

Are poseida Therapeutics (PsTx) earnings and revenue surprises a good investment?

Poseida Therapeutics, Inc. (PSTX) delivered earnings and revenue surprises of 39.62% and 100.13%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? It's not possible to invest over long periods without making some bad investments. But you want to avoid the really big... ...

Who owns poseida Therapeutics Inc?

Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA. PSTX | Complete Poseida Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

What happened to poseida Therapeutics?

Poseida’s rally comes as the company made some board changes including the resignation of its founder that spearheaded the company's spinout from the parent company- Transposagen in 2015. Poseida Therapeutics, Inc. announced that it had positive preclinical data for the treatment of Hemophilia A with the use of P-FVIII-101. ...